Catheter Precision Inc VTAK
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.65
- Day Range
- $0.55–0.72
- 52-Week Range
- $0.55–4.94
- Bid/Ask
- $0.73 / $0.73
- Shares Outstanding
- 3.61M
- Market Cap
- $2.02M
- Volume/Avg
- 22M / 7M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.87
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 17
Valuation
|
Metric
|
VTAK
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.18 |
Price/Sales | 0.87 |
Price/Cash Flow | — |
Price/Earnings
VTAK
Financial Strength
|
Metric
|
VTAK
|
|---|---|
Quick Ratio | 0.04 |
Current Ratio | 0.06 |
Interest Coverage | −46.35 |
Quick Ratio
VTAK
Profitability
|
Metric
|
VTAK
|
|---|---|
Return on Assets (Normalized) | −15.26% |
Return on Equity (Normalized) | −50.76% |
Return on Invested Capital (Normalized) | −28.95% |
Return on Assets
VTAK
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|Bm<?NQ | LOCK|!#>@ | $160B | |||
| Stryker Corp
SYK
| LOCK|#XZtk?< | LOCK|W> | $127B | |||
| Medtronic PLC
MDT
| LOCK|%%k@N^ | LOCK|QR#Gl | $107B | |||
| Boston Scientific Corp
BSX
| LOCK|vD?BYpw | LOCK|?kjJ | $66B | |||
| Edwards Lifesciences Corp
EW
| LOCK|P<@sFt@ | LOCK|?cL!s | $53B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|j!?w!N | LOCK|N? | $30B | |||
| DexCom Inc
DXCM
| LOCK|y&kJgwY> | LOCK|m$J? | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|#@ | LOCK|%cN | $27B | |||
| Steris PLC
STE
| LOCK|C@M@g< | LOCK|#pRZH | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|?dP>&^l | LOCK|<m? | $18B |
United States